Intranasal Treatment With 1, 25-Dihydroxyvitamin D3 Alleviates Allergic Rhinitis Symptoms in a Mouse Model

Abstract

Purpose Vitamin D is a potent immunomodulator. However, its role in the pathogenesis of allergic rhinitis is unclear. Methods The aim of this study was to evaluate the antiallergic effect of intranasally applied vitamin D in an allergic rhinitis mouse model. BALB/c mice were intraperitoneally sensitized with ovalbumin (OVA) and alum before they were intranasally challenged with OVA. Then, they were intranasally administered 1, 25-dihydroxyvitamin D3 (0.02 μg) or solvent. Allergic symptom scores, eosinophil infiltration, cytokine mRNA levels (interleukin [IL]-4, IL-5, IL-10, IL-13 and interferon-γ) in the nasal tissue, and serum total immunoglobulin E (IgE) and OVA-specific IgE, IgG1, and IgG2a were analyzed and compared with negative and positive control groups. Cervical lymph nodes (LNs) were harvested for flow cytometry analysis and cell proliferation assay. Results In the treatment group, allergic symptom scores, eosinophil infiltration, and mRNA levels of IL-4 and IL-13 were significantly lower in the nasal tissue than in the positive control group. The IL-5 mRNA level, serum total IgE, and OVA-specific IgE and IgG1 levels decreased in the treatment group; however, the difference was not significant. In the cervical LNs, CD86 expression had been down-regulated in CD11c + major histocompatibility complex II-high (MHCII high ) in the treatment group. Additionally, IL-4 secretion in the lymphocyte culture from cervical LNs significantly decreased. Conclusions The results confirm the antiallergic effect of intranasal 1,25-dihydroxyvitamin D3. It decreases CD 86 expression among CD11c + MHCII high cells and T-helper type 2-mediated inflammation in the cervical LNs. Therefore, topically applied 1,25-dihydroxyvitamin D3 can be a future therapeutic agent for allergic rhinitis.

Vancomycin-induced gut microbiota dysbiosis aggravates allergic rhinitis in mice by altered short-chain fatty acids

“…For inducing gut dysbiosis, four-week-old mice of the Van group were exposed to vancomycin in drinking water (200 mg/l vancomycin hydrochloride MCE, HY-17362) for 2 weeks before primary abdominal OVA sensitization, and then water was replaced with normal water. The OVA-induced AR model was established according to previous literature with a few modifications ( Cho et al, 2019 ). Briefly, 6-week-old mice were intraperitoneally injected with 0.2 ml of sensitization solution (40 μg OVA and 4 μg Imject™ Alum Adjuvant in 100 μl of PBS) on days 0, 7, 14, and 21.…”

Knockdown of miR‑205‑5p alleviates the inflammatory response in allergic rhinitis by targeting B‑cell lymphoma 6

“…After a 1-week acclimation period, all mice were randomly divided into the Sham, AR, AR + negative control (NC) and AR + Lv-anti-miR-205-5p sponge groups. A mouse model of AR was established according to a previous study ( 32 ). As shown in Fig.…”

Suppression of leukotriene B 4 production is involved in the anti-pruritic action of Grifola frondosa in pollen allergy-induced ocular itching in mice

“…In addition to ergosterol, vitamin D has been reported as an active ingredient in G. frondosa with anti-allergic effects (Liu et al, 2017;Cho et al, 2019). Oral administration of vitamin D in humans did not affect the serum concentration of LTB 4 compared with the placebo (Gendelman et al, 2015).…”